Rallybio (RLYB) EPS (Weighted Average and Diluted) (2023 - 2025)
Historic EPS (Weighted Average and Diluted) for Rallybio (RLYB) over the last 3 years, with Q3 2025 value amounting to $0.36.
- Rallybio's EPS (Weighted Average and Diluted) rose 23846.15% to $0.36 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.32, marking a year-over-year increase of 7987.42%. This contributed to the annual value of -$1.28 for FY2024, which is 3068.61% up from last year.
- Rallybio's EPS (Weighted Average and Diluted) amounted to $0.36 in Q3 2025, which was up 23846.15% from -$0.22 recorded in Q2 2025.
- Rallybio's 5-year EPS (Weighted Average and Diluted) high stood at $0.36 for Q3 2025, and its period low was -$0.49 during Q4 2023.
- For the 3-year period, Rallybio's EPS (Weighted Average and Diluted) averaged around -$0.29, with its median value being -$0.37 (2024).
- As far as peak fluctuations go, Rallybio's EPS (Weighted Average and Diluted) plummeted by 930.23% in 2024, and later skyrocketed by 23846.15% in 2025.
- Rallybio's EPS (Weighted Average and Diluted) (Quarter) stood at -$0.49 in 2023, then skyrocketed by 50.26% to -$0.24 in 2024, then soared by 247.69% to $0.36 in 2025.
- Its last three reported values are $0.36 in Q3 2025, -$0.22 for Q2 2025, and -$0.21 during Q1 2025.